Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

PubWeight™: 7.62‹?› | Rank: Top 0.1%

🔗 View Article (PMID 10737280)

Published in Arch Intern Med on March 27, 2000

Authors

J A Heit1, M D Silverstein, D N Mohr, T M Petterson, W M O'Fallon, L J Melton

Author Affiliations

1: Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA. heit.john@mayo.edu

Associated clinical trials:

Dedicated Ambulator-assisted Physical Activity to Improve Hospital Outcome Measures in Elderly Patients | NCT02757131

Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs (MYELAXAT) | NCT02066454

EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial (EXPECT) | NCT01853202

National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients (CARMEN) | NCT01362933

Articles citing this

(truncated to the top 100)

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.99

British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.02

Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ (2009) 4.99

Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47

Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood (2008) 4.06

The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol (2008) 3.50

Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol (2010) 2.56

Venous thromboembolism in the outpatient setting. Arch Intern Med (2007) 2.46

Physical inactivity and idiopathic pulmonary embolism in women: prospective study. BMJ (2011) 2.34

Pulmonary embolism in hospital practice. BMJ (2006) 2.27

Assessment of postoperative venous thromboembolism risk in plastic surgery patients using the 2005 and 2010 Caprini Risk score. Plast Reconstr Surg (2012) 2.25

Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol (2009) 2.22

Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis. J Thromb Thrombolysis (2014) 2.07

Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res (2009) 2.04

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood (2010) 1.89

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood (2008) 1.78

American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med (2001) 1.70

Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thromb Res (2010) 1.66

Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism. Eur Urol (2012) 1.65

Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg (2012) 1.65

Androgen deprivation and thromboembolic events in men with prostate cancer. Cancer (2011) 1.62

Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med (2012) 1.60

Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer (2007) 1.60

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases. Melanoma Res (2012) 1.55

Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice. J Thromb Haemost (2015) 1.46

Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol (2009) 1.45

Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). Cancer (2014) 1.39

Clinical features from the history and physical examination that predict the presence or absence of pulmonary embolism in symptomatic emergency department patients: results of a prospective, multicenter study. Ann Emerg Med (2010) 1.37

Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments. Chest (2014) 1.37

Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. Arterioscler Thromb Vasc Biol (2009) 1.34

Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum (2012) 1.34

Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ (2011) 1.33

A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost (2012) 1.23

Cancer-associated thrombosis: an overview. Clin Med Insights Oncol (2014) 1.23

Venous thromboembolic disease and cancer. Postgrad Med J (2006) 1.23

Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol (2012) 1.17

Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica (2009) 1.15

Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: results of a prospective study. Postgrad Med J (2006) 1.15

Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood (2011) 1.14

New insights into cancer-associated thrombosis. Arterioscler Thromb Vasc Biol (2009) 1.11

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States. Clinicoecon Outcomes Res (2013) 1.09

Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07

The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res (2015) 1.07

A rare case of occipital stroke as a consequence of nonbacterial thrombotic endocarditis in ovarian clear cell carcinoma: a case report. Case Rep Neurol (2012) 1.05

Use of anticoagulants in elderly patients: practical recommendations. Clin Interv Aging (2009) 1.04

Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J Gastroenterol (2006) 1.04

Treatment of Brain Metastases. J Clin Oncol (2015) 1.03

Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine. Clin Exp Med (2013) 1.01

Prolonged patients' In-Hospital Waiting Period after discharge eligibility is associated with increased risk of infection, morbidity and mortality: a retrospective cohort analysis. BMC Health Serv Res (2015) 1.00

The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00

Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review. J Exp Clin Cancer Res (2008) 0.99

Neoadjuvant-intensified treatment for rectal cancer: time to change? World J Gastroenterol (2013) 0.99

Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients. Clin Exp Immunol (2014) 0.98

Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res (2007) 0.98

Learning to predict post-hospitalization VTE risk from EHR data. AMIA Annu Symp Proc (2012) 0.98

Cancer-associated thrombosis: clinical presentation and survival. Cancer Manag Res (2013) 0.98

Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res (2010) 0.96

Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case-control study. Vasc Med (2009) 0.96

Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood (2010) 0.96

Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome--a comprehensive cancer center experience. Vasc Health Risk Manag (2011) 0.95

Cancer-associated thrombosis: prevention and treatment. Curr Oncol (2008) 0.95

Treatment options for venous thromboembolism: lessons learnt from clinical trials. Thromb J (2014) 0.95

Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood (2014) 0.94

Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res (2014) 0.94

Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study. Haematologica (2013) 0.93

Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93

Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women. Curr Control Trials Cardiovasc Med (2001) 0.93

IVC filters may prevent fatal pulmonary embolism in musculoskeletal tumor surgery. Clin Orthop Relat Res (2008) 0.92

Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study. Br J Cancer (2011) 0.91

The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J (2011) 0.91

Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer. Cancer (2009) 0.90

Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford) (2009) 0.90

Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol (2011) 0.89

Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int (2010) 0.89

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study. J Transl Med (2011) 0.89

Incidence and risk factors for pulmonary embolism after primary musculoskeletal tumor surgery. Clin Orthop Relat Res (2013) 0.88

Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management. Curr Oncol (2014) 0.88

Thrombosis and cancer. Nat Rev Clin Oncol (2012) 0.88

Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist (2013) 0.87

The potential benefits of low-molecular-weight heparins in cancer patients. J Hematol Oncol (2010) 0.87

Acute aortic thrombosis in patients receiving cisplatin-based chemotherapy. Curr Oncol (2011) 0.87

Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg (2006) 0.87

Venous thromboembolism and cancer risk among elderly adults in the United States. Cancer Epidemiol Biomarkers Prev (2014) 0.86

Primary prevention of venous thromboembolism in medical and surgical oncology patients. Br J Cancer (2010) 0.86

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag (2007) 0.86

Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review. World J Gastroenterol (2014) 0.86

Prevention of venous thromboembolism in hospitalized patients with cancer. J Clin Oncol (2009) 0.85

Venous thromboembolism: A problem in the Indian/Asian population? Indian J Urol (2009) 0.85

Acute pulmonary embolism. Part 1: epidemiology and diagnosis. Nat Rev Cardiol (2010) 0.85

Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci (2011) 0.85

Venous thromboembolism in cirrhosis: a review of the literature. Can J Gastroenterol (2012) 0.85

Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford) (2008) 0.84

Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer. Lung Cancer (2014) 0.84

Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Surgery (2015) 0.83

Evidence-based guidance on venous thromboembolism in patients with solid tumours. Curr Oncol (2014) 0.83

Implementing thrombosis guidelines in cancer patients: a review. Rambam Maimonides Med J (2014) 0.83

Inferior vena cava filters in cancer patients: to filter or not to filter. Ther Clin Risk Manag (2011) 0.83

The interplay of DNA methylation over time with Th2 pathway genetic variants on asthma risk and temporal asthma transition. Clin Epigenetics (2014) 0.83

Articles by these authors

Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91

The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25

Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Involutional osteoporosis. N Engl J Med (1986) 8.20

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49

Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22

Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24

Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13

Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77

Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63

The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol (2000) 3.62

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60

Yield of laboratory tests for case-finding in the ambulatory general medical examination. Am J Med (1996) 3.42

Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology (1988) 3.40

Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med (1997) 3.31

Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27

Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19

Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08

Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07

Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06

T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06

Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98

Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum (1999) 2.98

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

Epidemiology of anaphylaxis in Olmsted County: A population-based study. J Allergy Clin Immunol (1999) 2.95

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94

Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93

Standardized problem list generation, utilizing the Mayo canonical vocabulary embedded within the Unified Medical Language System. Proc AMIA Annu Fall Symp (1997) 2.93

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86

Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85

Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int (1999) 2.83

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood (1992) 2.81

Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80

Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med (1986) 2.80

Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79

Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79

Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74

Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72

Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation (1999) 2.71

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69

Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol (2000) 2.68

Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial. Mayo Clin Proc (2001) 2.61

Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med (1982) 2.58

Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56

Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. Mayo Clin Proc (1995) 2.55